Fuan pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Qingyu Hall Pharmaceutical Co., Ltd. (...)
According to Zhitong Finance APP, Fuan pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Qingyu Hall Pharmaceutical Co., Ltd. (referred to as "Qingyu Hall") and Fuan Pharmaceutical Group Hubei Renmin Pharmaceutical Co., Ltd. (referred to as "Renmin Pharmaceutical") have recently received the pharmaceutical registration certificates issued by the National Medical Products Administration, with the pharmaceutical names being Mefosbab injection and Clonixin injection.
It is reported that Mefosbab injection is mainly used for the treatment of acute skeletal muscle pain or discomfort symptoms. Clonixin injection is mainly used for the short-term treatment of moderate acute pain following surgery.